Regulating the genome surveillance system: MiRNAs and the p53 super family

Apoptosis

Volumn 15, Issue 5, 2010, Pages 541-552

  Bailey, Sarah G ^a   Sanchez Elsner, Tilman ^a   Stephanou, Anastasis ^b   Cragg, Mark S ^a   Townsend, Paul A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Leukaemia; Lymphoma; MiRNA; P53; P73

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 125A 5P; MICRORNA 125B; MICRORNA 143; MICRORNA 150; MICRORNA 155; MICRORNA 193A 5P; MICRORNA 19B; MICRORNA 22; MICRORNA 300; MICRORNA 330 5P; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C 3P; MICRORNA 34C 5P; MICRORNA 453; MICRORNA 485 5P; MICRORNA 493; MICRORNA 545; MICRORNA 612; MICRORNA 647; MICRORNA 650; MICRORNA 768 3P; MICRORNA 876 3P; MICRORNA 922; PROTEIN P53; PROTEIN P63; PROTEIN P73; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CANCER CELL; CARCINOGENESIS; DNA DAMAGE; DOWN REGULATION; EMBRYO DEVELOPMENT; EXON; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HEMATOLOGIC MALIGNANCY; HUMAN; INTRON; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; GENOME; HUMANS; MICRORNAS; MULTIGENE FAMILY; NEOPLASMS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 77951666837     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0456-1     Document Type: Review

References (153)

1. J Lukas C Lukas J Bartek 2004 Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time DNA Repair (Amst) 3 997 1007 10.1016/j.dnarep.2004.03.006 1:CAS:528:DC%2BD2cXmtVeqt74%3D (Pubitemid 38997942)
2. J Bartek J Lukas 2001 Pathways governing G1/S transition and their response to DNA damage FEBS Lett 490 117 122 11223026 10.1016/S0014-5793(01) 02114-7 1:CAS:528:DC%2BD3MXht1Ortrs%3D (Pubitemid 32171930)
3. CA Schmitt JS Fridman M Yang E Baranov RM Hoffman SW Lowe 2002 Dissecting p53 tumour suppressor functions in vivo Cancer Cell 1 289 298 12086865 10.1016/S1535-6108(02)00047-8 1:CAS:528:DC%2BD38XjsFGlt70%3D (Pubitemid 41039153)
4. T Megidish JH Xu CW Xu 2002 Activation of p53 by protein inhibitor of activated Stat1 (PIAS1) J Biol Chem 277 8255 8259 11788578 10.1074/jbc. C200001200 1:CAS:528:DC%2BD38XitFymtrk%3D (Pubitemid 34968283)
5. V Nelson GE Davis SA Maxwell 2001 A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis Apoptosis 6 221 234 11388671 10.1023/A:1011392811628 1:CAS:528:DC%2BD3MXktF2qur8%3D (Pubitemid 32423731)
6. A Olsson C Manzl A Strasser A Villunger 2007 How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14 1561 1575 17627286 10.1038/sj.cdd.4402196 1:CAS:528:DC%2BD2sXptFymurk%3D (Pubitemid 47278842)
7. A Scoumanne X Chen 2008 Protein methylation: a new mechanism of p53 tumour suppressor regulation Histol Histopathol 23 1143 1149 18581285 1:CAS:528:DC%2BD1cXptlKnsLs%3D
8. JD Siliciano CE Canman Y Taya K Sakaguchi E Appella MB Kastan 1997 DNA damage induces phosphorylation of the amino terminus of p53 Genes Dev 11 3471 3481 9407038 10.1101/gad.11.24.3471 1:CAS:528:DyaK1cXivFOqsg%3D%3D
9. J Huang R Sengupta AB Espejo, et al. 2007 p53 is regulated by the lysine demethylase LSD1 Nature 449 105 108 17805299 10.1038/nature06092 1:CAS:528:DC%2BD2sXpvFWrs7w%3D (Pubitemid 47373772)
10. G Dominguez JM Garcia C Pena, et al. 2006 DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1 J Clin Oncol 24 805 815 16380414 10.1200/JCO.2005.02.2350 1:CAS:528:DC%2BD28XitVGitrk%3D (Pubitemid 46622048)
11. TJ Grob U Novak C Maisse, et al. 2001 Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53 Cell Death Differ 8 1213 1223 11753569 10.1038/sj.cdd.4400962 1:CAS:528:DC%2BD38XmtVKksg%3D%3D (Pubitemid 34048476)
12. NN Kartasheva A Contente C Lenz-Stoppler J Roth M Dobbelstein 2002 p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop Oncogene 21 4715 4727 12101410 10.1038/sj.onc. 1205584 1:CAS:528:DC%2BD38XltVOmurk%3D (Pubitemid 34879447)
13. MA Sabatino S Previdi M Broggini 2007 In vivo evaluation of the role of DNp73 alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs Int J Cancer 120 506 513 17096333 10.1002/ijc.22362 1:CAS:528:DC%2BD28XhtlGqsrbI (Pubitemid 44969020)
14. T Stiewe CC Theseling BM Putzer 2002 Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis J Biol Chem 277 14177 14185 11844800 10.1074/jbc.M200480200 1:CAS:528:DC%2BD38XjsFWntLc%3D (Pubitemid 34968030)
15. PA Townsend TM Scarabelli SM Davidson RA Knight DS Latchman A Stephanou 2004 STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis J Biol Chem 279 5811 5820 14602726 10.1074/jbc.M302637200 1:CAS:528: DC%2BD2cXhtFCjs74%3D (Pubitemid 38220612)
16. S Vossio E Palescandolo N Pediconi, et al. 2002 DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest Oncogene 21 3796 3803 12032848 10.1038/sj.onc.1205465 1:CAS:528: DC%2BD38Xks1OjsLo%3D
17. S Wang WS El-Deiry 2006 p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints Cancer Res 66 6982 6989 16849542 10.1158/0008-5472.CAN-06-0511 1:CAS:528:DC%2BD28XmvFGktr8%3D (Pubitemid 44197673)
18. J Yu V Baron D Mercola T Mustelin ED Adamson 2007 A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells Cell Death Differ 14 436 446 16990849 10.1038/sj.cdd.4402029 1:CAS:528:DC%2BD2sXhslWhtr4%3D
19. AI Zaika N Slade SH Erster, et al. 2002 DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors J Exp Med 196 765 780 12235210 10.1084/jem.20020179 1:CAS:528:DC%2BD38Xnt1yht7c%3D
20. V Zuckerman K Wolyniec RV Sionov S Haupt Y Haupt 2009 Tumour suppression by p53: the importance of apoptosis and cellular senescence J Pathol 219 3 15 19562738 1:CAS:528:DC%2BD1MXhtFGgs7%2FP
21. KH Vousden KM Ryan 2009 p53 and metabolism Nat Rev Cancer 9 691 700 19759539 10.1038/nrc2715 1:CAS:528:DC%2BD1MXhtFentb%2FM
22. S Polager D Ginsberg 2009 p53 and E2f: partners in life and death Nat Rev Cancer 9 738 748 19776743 10.1038/nrc2718 1:CAS:528:DC%2BD1MXhtFKmsb%2FO
23. D Menendez A Inga MA Resnick 2009 The expanding universe of p53 targets Nat Rev Cancer 9 724 737 19776742 10.1038/nrc2730 1:CAS:528:DC%2BD1MXhtFKmsb7M
24. DW Meek 2009 Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9 714 723 19730431 1:CAS:528:DC%2BD1MXhtVygsbbL
25. Blaydes JP (2010) Cooperation between MDM2 and MDMX in the regulation of p53. In: Hupp T, Ayed A (eds). p53: Landes bioscience
26. JC Marine S Francoz M Maetens G Wahl F Toledo G Lozano 2006 Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 Cell Death Differ 13 927 934 16543935 10.1038/sj.cdd.4401912 1:CAS:528:DC%2BD28Xks1Ortbo%3D
27. D Michael M Oren 2003 The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 13 49 58 12507556 10.1016/S1044-579X(02)00099-8 1:CAS:528: DC%2BD38XpvVWksrw%3D (Pubitemid 36269180)
28. S Spange T Wagner T Heinzel OH Kramer 2009 Acetylation of non-histone proteins modulates cellular signalling at multiple levels Int J Biochem Cell Biol 41 185 198 18804549 10.1016/j.biocel.2008.08.027 1:CAS:528: DC%2BD1cXhsVWnu7zP
29. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 15838523 10.1038/sj.onc.1208615 1:CAS:528: DC%2BD2MXjtlehs7c%3D (Pubitemid 40638098)
30. T Riley E Sontag P Chen A Levine 2008 Transcriptional control of human p53-regulated genes Nat Rev Mol Cell Biol 9 402 412 18431400 10.1038/nrm2395 1:CAS:528:DC%2BD1cXkvF2gtL8%3D (Pubitemid 351574202)
31. B Levine J Abrams 2008 p53: the Janus of autophagy? Nat Cell Biol 10 637 639 18521069 10.1038/ncb0608-637 1:CAS:528:DC%2BD1cXmsFyksLs%3D (Pubitemid 351772928)
32. T Miyashita JC Reed 1995 Tumour suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 293 299 7834749 10.1016/0092-8674(95)90513-8 1:CAS:528:DyaK2MXjtlGns7w%3D
33. E Oda R Ohki H Murasawa, et al. 2000 Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 1053 1058 10807576 10.1126/science.288.5468.1053 1:CAS:528:DC%2BD3cXjsVSnsbg%3D (Pubitemid 30324238)
34. K Nakano KH Vousden 2001 PUMA, a novel proapoptotic gene, is induced by p53 Mol Cell 7 683 694 11463392 10.1016/S1097-2765(01)00214-3 1:CAS:528:DC%2BD3MXivVCmtLk%3D (Pubitemid 32706359)
35. A Villunger EM Michalak L Coultas, et al. 2003 p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa Science 302 1036 1038 14500851 10.1126/science.1090072 1:CAS:528:DC%2BD3sXos1CmsLk%3D (Pubitemid 37386194)
36. E Michalak A Villunger M Erlacher A Strasser 2005 Death squads enlisted by the tumour suppressor p53 Biochem Biophys Res Commun 331 786 798 15865934 10.1016/j.bbrc.2005.03.183 1:CAS:528:DC%2BD2MXjslKjtL8%3D (Pubitemid 40615509)
37. D Munsch R Watanabe-Fukunaga JC Bourdon, et al. 2000 Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis J Biol Chem 275 3867 3872 10660538 10.1074/jbc.275.6.3867 1:CAS:528:DC%2BD3cXht12gsrk%3D (Pubitemid 30094610)
38. F Murray-Zmijewski DP Lane JC Bourdon 2006 p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress Cell Death Differ 13 962 972 16601753 10.1038/sj.cdd.4401914 1:CAS:528:DC%2BD28Xks1Ortbg%3D
39. M Kaghad H Bonnet A Yang, et al. 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 809 819 9288759 10.1016/S0092-8674(00)80540-1 1:CAS:528:DyaK2sXlvFKmurY%3D (Pubitemid 27357971)
40. A Scoumanne KL Harms X Chen 2005 Structural basis for gene activation by p53 family members Cancer Biol Ther 4 1178 1185 16294021 1:CAS:528: DC%2BD28XkvFGhtL4%3D
41. WG Kaelin Jr 1999 The p53 gene family Oncogene 18 7701 7705 10618710 10.1038/sj.onc.1202955 1:CAS:528:DC%2BD3cXmt1SrtQ%3D%3D
42. O Ishimoto C Kawahara K Enjo M Obinata T Nukiwa S Ikawa 2002 Possible oncogenic potential of Delta N p73: a newly identified isoform of human p73 Cancer Res 62 636 641 11830511 1:CAS:528:DC%2BD38Xht1KrtLk%3D
43. A Yang N Walker R Bronson, et al. 2000 p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours Nature 404 99 103 10716451 10.1038/35003607 1:CAS:528:DC%2BD3cXhvVyqtbo%3D (Pubitemid 30143141)
44. A Yang M Kaghad Y Wang, et al. 1998 p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 2 305 316 9774969 10.1016/S1097-2765(00) 80275-0 1:CAS:528:DyaK1cXmsVyqt7c%3D
45. S Courtois G Verhaegh S North, et al. 2002 Delta N-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 Oncogene 21 6722 6728 12360399 10.1038/sj.onc.1205874 1:CAS:528:DC%2BD38XntFentb0%3D
46. JC Bourdon K Fernandes F Murray-Zmijewski, et al. 2005 p53 isoforms can regulate p53 transcriptional activity Genes Dev 19 2122 2137 16131611 10.1101/gad.1339905 1:CAS:528:DC%2BD2MXhtVGlsrzP (Pubitemid 41330315)
47. G Rohaly J Chemnitz S Dehde, et al. 2005 A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint Cell 122 21 32 16009130 10.1016/j.cell.2005.04.032 1:CAS:528:DC%2BD2MXmsFeitbs%3D (Pubitemid 40977937)
48. V De Laurenzi A Costanzo D Barcaroli, et al. 1998 Two new p73 splice variants, gamma and delta, with different transcriptional activity J Exp Med 188 1763 1768 9802988 10.1084/jem.188.9.1763 (Pubitemid 28516121)
49. VD De Laurenzi MV Catani A Terrinoni, et al. 1999 Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta Cell Death Differ 6 389 390 10381648 10.1038/sj.cdd.4400521 1:CAS:528:DyaK1MXjvFCmsLs%3D
50. Y Ueda M Hijikata S Takagi T Chiba K Shimotohno 1999 New p73 variants with altered C-terminal structures have varied transcriptional activities Oncogene 18 4993 4998 10490834 10.1038/sj.onc.1202817 1:CAS:528: DyaK1MXmt1Srtbo%3D (Pubitemid 29425306)
51. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 11099028 10.1038/35042675 1:CAS:528:DC%2BD3cXosVemtrY%3D
52. N Concin G Hofstetter A Berger, et al. 2005 Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo Clin Cancer Res 11 8372 8383 16322298 10.1158/1078-0432.CCR-05-0899 1:CAS:528: DC%2BD2MXht1KjsrnK (Pubitemid 41746950)
53. M Lanza B Marinari M Papoutsaki, et al. 2006 Cross-talks in the p53 family: delta N p63 is an anti-apoptotic target for delta N p73alpha and p53 gain-of-function mutants Cell Cycle 5 1996 2004 16931914 1:CAS:528: DC%2BD28XhtlWqsLjL
54. AL Gartel 2008 Transcriptional inhibitors, p53 and apoptoss Biochim Biophys Acta 1786 83 86 18503775 1:CAS:528:DC%2BD1cXhtlyhsLjL
55. L He X He LP Lim, et al. 2007 A microRNA component of the p53 tumour suppressor network Nature 447 1130 1134 17554337 10.1038/nature05939 1:CAS:528:DC%2BD2sXmvFKmu7c%3D (Pubitemid 47014436)
56. X He L He GJ Hannon 2007 The guardian's little helper: microRNAs in the p53 tumour suppressor network Cancer Res 67 11099 11101 18056431 10.1158/0008-5472.CAN-07-2672 1:CAS:528:DC%2BD2sXhtlyiurrE (Pubitemid 350248530)
57. H Hermeking 2007 p53 enters the microRNA world Cancer Cell 12 414 418 17996645 10.1016/j.ccr.2007.10.028 1:CAS:528:DC%2BD2sXhtl2nur3E (Pubitemid 350046413)
58. G Blandino UM Moll 2009 p63 regulation by microRNAs Cell Cycle 8 1466 1467 19411828 1:CAS:528:DC%2BD1MXptVWqtL4%3D
59. V Ambros 2004 The functions of animal microRNAs Nature 431 350 355 15372042 10.1038/nature02871 1:CAS:528:DC%2BD2cXnsFaiu7g%3D (Pubitemid 39265675)
60. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 281 297 14744438 10.1016/S0092-8674(04)00045-5 1:CAS:528: DC%2BD2cXhtVals7o%3D (Pubitemid 38167318)
61. LP Lim ME Glasner S Yekta CB Burge DP Bartel 2003 Vertebrate microRNA genes Science 299 1540 12624257 10.1126/science.1080372 1:CAS:528: DC%2BD3sXjtFahtr8%3D (Pubitemid 36297696)
62. RC Lee RL Feinbaum V Ambros 1993 The C. elegans heterochronic gene line-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 843 854 8252621 10.1016/0092-8674(93)90529-Y 1:CAS:528:DyaK2cXpslGqtA%3D%3D (Pubitemid 24014542)
63. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 259 269 16557279 10.1038/nrc1840 1:CAS:528: DC%2BD28XivVyqtrs%3D
64. A Israel R Sharan E Ruppin E Galun 2009 Increased microRNA activity in human cancers PLoS One 4 e6045 19557174 10.1371/journal.pone.0006045 1:CAS:528:DC%2BD1MXnvVGlsr8%3D
65. GA Calin A Cimmino M Fabbri, et al. 2008 MiR-15a and miR-16-1 cluster functions in human leukemia Proc Natl Acad Sci USA 105 5166 5171 18362358 10.1073/pnas.0800121105 (Pubitemid 351738528)
66. GA Calin CD Dumitru M Shimizu, et al. 2002 Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci USA 99 15524 15529 12434020 10.1073/pnas.242606799 1:CAS:528:DC%2BD3sXjvVOl (Pubitemid 35403967)
67. M Mraz K Malinova J Kotaskova, et al. 2009 miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities Leukemia 23 1159 1163 19158830 10.1038/leu.2008.377 1:CAS:528:DC%2BD1MXntFygtLY%3D
68. M Mraz S Pospisilova K Malinova I Slapak J Mayer 2009 MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes Leuk Lymphoma 50 506 509 19347736 10.1080/10428190902763517 1:CAS:528:DC%2BD1MXktVKitr4%3D
69. MS Nicoloso TJ Kipps CM Croce GA Calin 2007 MicroRNAs in the pathogeny of chronic lymphocytic leukaemia Br J Haematol 139 709 716 18021085 10.1111/j.1365-2141.2007.06868.x 1:CAS:528:DC%2BD1cXhs12gtbw%3D (Pubitemid 350115732)
70. A Cimmino GA Calin M Fabbri, et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci USA 102 13944 13949 16166262 10.1073/pnas.0506654102 1:CAS:528:DC%2BD2MXhtVOqsbjK (Pubitemid 41377683)
71. PS Eis W Tam L Sun, et al. 2005 Accumulation of miR-155 and BIC RNA in human B cell lymphomas Proc Natl Acad Sci USA 102 3627 3632 15738415 10.1073/pnas.0500613102 1:CAS:528:DC%2BD2MXisVOgsL8%3D (Pubitemid 40354662)
72. M Inomata H Tagawa YM Guo Y Kameoka N Takahashi K Sawada 2009 MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes Blood 113 396 402 18941111 10.1182/blood-2008-07-163907 1:CAS:528:DC%2BD1MXptFShsg%3D%3D
73. CH Lawrie S Soneji T Marafioti, et al. 2007 MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma Int J Cancer 121 1156 1161 17487835 10.1002/ijc.22800 1:CAS:528:DC%2BD2sXhtFGhu7nP (Pubitemid 47101656)
74. J Lu G Getz EA Miska, et al. 2005 MicroRNA expression profiles classify human cancers Nature 435 834 838 15944708 10.1038/nature03702 1:CAS:528:DC%2BD2MXkvVGgsLc%3D (Pubitemid 40839735)
75. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
76. H Liu IS Kohane 2009 Tissue and process specific microRNA-mRNA co-expression in mammalian development and malignancy PLoS One 4 e5436 19415117 10.1371/journal.pone.0005436 1:CAS:528:DC%2BD1MXlvFyrtLg%3D
77. A Ventura T Jacks 2009 MicroRNAs and cancer: short RNAs go a long way Cell 136 586 591 19239879 10.1016/j.cell.2009.02.005 1:CAS:528: DC%2BD1MXkvFGksLg%3D
78. A Ota H Tagawa S Karnan, et al. 2004 Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma Cancer Res 64 3087 3095 15126345 10.1158/0008-5472.CAN-03-3773 1:CAS:528:DC%2BD2cXjs1ehtr0%3D (Pubitemid 38581408)
79. T Zenz A Benner H Dohner S Stilgenbauer 2008 Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway Cell Cycle 7 3810 3814 19098429 1:CAS:528:DC%2BD1MXhvVSitrs%3D
80. S Tashiro M Takechi H Asou, et al. 1992 Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobulin light chain genes Oncogene 7 573 577 1549371 1:CAS:528: DyaK38Xitlaqt7c%3D
81. M Lagos-Quintana R Rauhut A Yalcin J Meyer W Lendeckel T Tuschl 2002 Identification of tissue-specific microRNAs from mouse Curr Biol 12 735 739 12007417 10.1016/S0960-9822(02)00809-6 1:CAS:528:DC%2BD38XjsFygtb4%3D (Pubitemid 34455427)
82. I Faraoni FR Antonetti J Cardone E Bonmassar 2009 miR-155 gene: a typical multifunctional microRNA Biochim Biophys Acta 1792 497 505 19268705 1:CAS:528:DC%2BD1MXmvFCrtbw%3D
83. KD Taganov MP Boldin KJ Chang D Baltimore 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses Proc Natl Acad Sci USA 103 12481 12486 16885212 10.1073/pnas.0605298103 1:CAS:528:DC%2BD28Xos1Kqt7g%3D (Pubitemid 44267285)
84. RM O'Connell KD Taganov MP Boldin G Cheng D Baltimore 2007 MicroRNA-155 is induced during the macrophage inflammatory response Proc Natl Acad Sci USA 104 1604 1609 17242365 10.1073/pnas.0610731104 1:CAS:528:DC%2BD2sXhslejtLo%3D (Pubitemid 46214637)
85. J Kluiver S Poppema D de Jong, et al. 2005 BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas J Pathol 207 243 249 16041695 10.1002/path.1825 1:CAS:528:DC%2BD2MXhtFKnsr%2FI (Pubitemid 41404155)
86. JT Mendell 2008 miRiad roles for the miR-17-92 cluster in development and disease Cell 133 217 222 18423194 10.1016/j.cell.2008.04.001 1:CAS:528:DC%2BD1cXltlWnurY%3D (Pubitemid 351508308)
87. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 839 843 15944709 10.1038/nature03677 1:CAS:528:DC%2BD2MXkvVGgsLg%3D (Pubitemid 40839736)
88. L He JM Thomson MT Hemann, et al. 2005 A microRNA polycistron as a potential human oncogene Nature 435 828 833 15944707 10.1038/nature03552 1:CAS:528:DC%2BD2MXkvVGgs70%3D (Pubitemid 40839734)
89. I Ivanovska AS Ball RL Diaz, et al. 2008 MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression Mol Cell Biol 28 2167 2174 18212054 10.1128/MCB.01977-07 1:CAS:528:DC%2BD1cXjvFemt7g%3D (Pubitemid 351429964)
90. T Boren Y Xiong A Hakam, et al. 2009 MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy Gynecol Oncol 113 249 255 19237188 10.1016/j.ygyno.2009.01.014 1:CAS:528:DC%2BD1MXktlygtLg%3D
91. MT Le C Teh N Shyh-Chang, et al. 2009 MicroRNA-125b is a novel negative regulator of p53 Genes Dev 23 862 876 19293287 10.1101/gad.1767609 1:CAS:528:DC%2BD1MXks1Sruro%3D
92. GT Bommer I Gerin Y Feng, et al. 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes Curr Biol 17 1298 1307 17656095 10.1016/j.cub.2007.06.068 1:CAS:528:DC%2BD2sXosF2ju7o%3D (Pubitemid 47176893)
93. CJ Braun X Zhang I Savelyeva, et al. 2008 p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest Cancer Res 68 10094 10104 19074875 10.1158/0008-5472.CAN-08-1569 1:CAS:528:DC%2BD1cXhsV2it7bF
94. R Brosh R Shalgi A Liran, et al. 2008 p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation Mol Syst Biol 4 229 19034270 10.1038/msb.2008.65 1:CAS:528:DC%2BD1cXhsFWksLjJ (Pubitemid 352790839)
95. TC Chang EA Wentzel OA Kent, et al. 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Mol Cell 26 745 752 17540599 10.1016/j.molcel.2007.05.010 1:CAS:528:DC%2BD2sXnt1Cquro%3D (Pubitemid 46856245)
96. DC Corney A Flesken-Nikitin AK Godwin W Wang AY Nikitin 2007 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth Cancer Res 67 8433 8438 17823410 10.1158/0008-5472.CAN-07-1585 1:CAS:528:DC%2BD2sXhtVCit7%2FF (Pubitemid 47437414)
97. SA Georges MC Biery SY Kim, et al. 2008 Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215 Cancer Res 68 10105 10112 19074876 10.1158/0008-5472.CAN-08-1846 1:CAS:528:DC%2BD1cXhsV2it7fM
98. Q Ji X Hao Y Meng, et al. 2008 Restoration of tumour suppressor miR-34 inhibits human p53-mutant gastric cancer tumour spheres BMC Cancer 8 266 18803879 10.1186/1471-2407-8-266 1:CAS:528:DC%2BD1cXhtlWju7zJ
99. M Sachdeva S Zhu F Wu, et al. 2009 p53 represses c-Myc through induction of the tumour suppressor miR-145 Proc Natl Acad Sci USA 106 3207 3212 19202062 10.1073/pnas.0808042106
100. V Tarasov P Jung B Verdoodt, et al. 2007 Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest Cell Cycle 6 1586 1593 17554199 1:CAS:528:DC%2BD2sXhtFWlsr3O
101. E Tili JJ Michaille A Cimino, et al. 2007 Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock J Immunol 179 5082 5089 17911593 1:CAS:528:DC%2BD2sXhtFWitrvM
102. ND Mendes AT Freitas MF Sagot 2009 Current tools for the identification of miRNA genes and their targets Nucleic Acids Res 37 2419 2433 19295136 10.1093/nar/gkp145 1:CAS:528:DC%2BD1MXlslerurc%3D
103. BP Lewis IH Shih MW Jones-Rhoades DP Bartel CB Burge 2003 Prediction of mammalian microRNA targets Cell 115 787 798 14697198 10.1016/S0092-8674(03) 01018-3 1:CAS:528:DC%2BD2cXhsFCnsw%3D%3D (Pubitemid 38058492)
104. S Griffiths-Jones 2004 The microRNA Registry Nucleic Acids Res 32 D109 D111 14681370 10.1093/nar/gkh023 1:CAS:528:DC%2BD2cXjtVartrg%3D
105. S Griffiths-Jones HK Saini S van Dongen AJ Enright 2008 miRBase: tools for microRNA genomics Nucleic Acids Res 36 D154 D158 17991681 10.1093/nar/gkm952 1:CAS:528:DC%2BD1cXhtVWjsb8%3D (Pubitemid 351149713)
106. AJ Enright B John U Gaul T Tuschl C Sander DS Marks 2003 MicroRNA targets in Drosophila Genome Biol 5 R1 14709173 10.1186/gb-2003-5-1-r1
107. M Kertesz N Iovino U Unnerstall U Gaul E Segal 2007 The role of site accessibility in microRNA target recognition Nat Genet 39 1278 1284 17893677 10.1038/ng2135 1:CAS:528:DC%2BD2sXhtV2isL7P (Pubitemid 47482690)
108. D Iliopoulos KN Malizos P Oikonomou A Tsezou 2008 Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks PLoS One 3 e3740 19011694 10.1371/journal.pone.0003740 1:CAS:528:DC%2BD1cXhsVartr3E
109. DP Pandey D Picard 2009 miR-22 inhibits estrogen signalling by directly targeting the estrogen receptor alpha mRNA Mol Cell Biol 29 3783 3790 19414598 10.1128/MCB.01875-08 1:CAS:528:DC%2BD1MXotlCqu74%3D
110. LP Tan M Wang JL Robertus, et al. 2009 miRNA profiling of B-cell subsets: specific miRNA profile for germinal centre B cells with variation between centroblasts and centrocytes Lab Invest 89 708 716 19349957 10.1038/labinvest. 2009.26 1:CAS:528:DC%2BD1MXmsVOrtb0%3D
111. D Lodygin V Tarasov A Epanchintsev, et al. 2008 Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer Cell Cycle 7 2591 2600 18719384 1:CAS:528:DC%2BD1cXht1elsbnO
112. M Collado MA Blasco M Serrano 2007 Cellular senescence in cancer and aging Cell 130 223 233 17662938 10.1016/j.cell.2007.07.003 1:CAS:528: DC%2BD2sXovFaltrc%3D (Pubitemid 47081143)
113. H Hermeking 2009 MiR-34a and p53 Cell Cycle 8 1308 19342875
114. N Raver-Shapira M Oren 2007 Tiny actors, great roles: microRNAs in p53's service Cell Cycle 6 2656 2661 17957137 1:CAS:528:DC%2BD1cXhsFyktQ%3D%3D
115. HI Suzuki K Yamagata K Sugimoto T Iwamoto S Kato K Miyazono 2009 Modulation of microRNA processing by p53 Nature 460 529 533 19626115 10.1038/nature08199 1:CAS:528:DC%2BD1MXovFymtL0%3D
116. D Goldschneider E Horvilleur LF Plassa, et al. 2006 Expression of C-terminal deleted p53 isoforms in neuroblastoma Nucleic Acids Res 34 5603 5612 17028100 10.1093/nar/gkl619 1:CAS:528:DC%2BD28Xht1Srt7bL (Pubitemid 44742447)
117. L Boldrup JC Bourdon PJ Coates B Sjostrom K Nylander 2007 Expression of p53 isoforms in squamous cell carcinoma of the head and neck Eur J Cancer 43 617 623 17215121 10.1016/j.ejca.2006.10.019 1:CAS:528:DC%2BD2sXhsVSjsbs%3D (Pubitemid 46177591)
118. M Ebrahimi L Boldrup PJ Coates YB Wahlin JC Bourdon K Nylander 2008 Expression of novel p53 isoforms in oral lichen planus Oral Oncol 44 156 161 17418619 10.1016/j.oraloncology.2007.01.014 1:CAS:528:DC%2BD1cXhsVKht7w%3D (Pubitemid 351179660)
119. KA Avery-Kiejda XD Zhang LJ Adams, et al. 2008 Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin Clin Cancer Res 14 1659 1668 18310316 10.1158/1078-0432.CCR-07-1422 1:CAS:528:DC%2BD1cXjtlejt7w%3D (Pubitemid 351469449)
120. J Chen SM Ng C Chang, et al. 2009 p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish Genes Dev 23 278 290 19204115 10.1101/gad.1761609 1:CAS:528:DC%2BD1MXit1Kgt7c%3D
121. Baffa R, Fassan M, Volinia S, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol
122. AW Tong P Fulgham C Jay, et al. 2009 MicroRNA profile analysis of human prostate cancers Cancer Gene Ther 16 206 216 18949015 1:CAS:528: DC%2BD1MXhslSnsb4%3D
123. A Costanzo P Merlo N Pediconi, et al. 2002 DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes Mol Cell 9 175 186 11804596 10.1016/S1097-2765(02)00431-8 1:CAS:528: DC%2BD38XhtVyjsLc%3D (Pubitemid 34127781)
124. I Fillippovich N Sorokina M Gatei, et al. 2001 Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53 Oncogene 20 514 522 11313982 10.1038/sj.onc.1204118 1:CAS:528:DC%2BD3MXhsVKjtb4%3D (Pubitemid 32158231)
125. M Irwin MC Marin AC Phillips, et al. 2000 Role for the p53 homologue p73 in E2F-1-induced apoptosis Nature 407 645 648 11034215 10.1038/35036614 1:CAS:528:DC%2BD3cXnsVOkurk%3D
126. N Jain S Gupta C Sudhakar V Radha G Swarup 2005 Role of p73 in regulating human caspase-1 gene transcription induced by interferon-{gamma} and cisplatin J Biol Chem 280 36664 36673 16135520 10.1074/jbc.M413261200 1:CAS:528: DC%2BD2MXhtFKht7fE (Pubitemid 41587744)
127. G Melino F Bernassola M Ranalli, et al. 2004 p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation J Biol Chem 279 8076 8083 14634023 10.1074/jbc.M307469200 1:CAS:528:DC%2BD2cXhsFejtbo%3D (Pubitemid 38294697)
128. J Zhu S Nozell J Wang J Jiang W Zhou X Chen 2001 p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner Oncogene 20 4050 4057 11494133 10.1038/sj.onc.1204516 1:CAS:528: DC%2BD3MXlsVent70%3D (Pubitemid 32681610)
129. T Stiewe BM Putzer 2000 Role of the p53-homologue p73 in E2F1-induced apoptosis Nat Genet 26 464 469 11101847 10.1038/82617 1:CAS:528: DC%2BD3cXptVWgtrc%3D
130. M Cuadros G Ribas V Fernandez C Rivas J Benitez B Martinez-Delgado 2006 Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas Leuk Res 30 170 177 16083956 10.1016/j.leukres.2005.06. 024 1:CAS:528:DC%2BD2MXhtlSiu7bM (Pubitemid 41773337)
131. M Meier ML den Boer JP Meijerink, et al. 2006 Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia Leukemia 20 1377 1384 16791269 10.1038/sj.leu.2404288 1:CAS:528:DC%2BD28XntVWksrs%3D (Pubitemid 44084050)
132. N Concin K Becker N Slade, et al. 2004 Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo Cancer Res 64 2449 2460 15059898 10.1158/0008-5472.CAN-03-1060 1:CAS:528:DC%2BD2cXis1yjtbw%3D (Pubitemid 38523899)
133. M Marabese S Marchini E Marrazzo, et al. 2008 Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer Eur J Cancer 44 131 141 18039564 10.1016/j.ejca.2007.10.011 1:CAS:528:DC%2BD2sXhsVOrurrI (Pubitemid 350256944)
134. M Muller T Schilling AE Sayan, et al. 2005 TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma Cell Death Differ 12 1564 1577 16195739 10.1038/sj.cdd.4401774 1:CAS:528:DC%2BD2MXhtF2ktb7E (Pubitemid 41679162)
135. D Levy Y Adamovich N Reuven Y Shaul 2007 The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73 Cell Death Differ 14 743 751 17110958 10.1038/sj.cdd.4402063 1:CAS:528:DC%2BD2sXjt1Sku7k%3D (Pubitemid 46444512)
136. A Oberst M Rossi P Salomoni, et al. 2005 Regulation of the p73 protein stability and degradation Biochem Biophys Res Commun 331 707 712 15865926 10.1016/j.bbrc.2005.03.158 1:CAS:528:DC%2BD2MXjslKjt70%3D (Pubitemid 40615501)
137. M Rossi V De Laurenzi E Munarriz, et al. 2005 The ubiquitin-protein ligase Itch regulates p73 stability EMBO J 24 836 848 15678106 10.1038/sj.emboj.7600444 1:CAS:528:DC%2BD2MXhsFWlsLg%3D (Pubitemid 40396112)
138. D Sampath GA Calin VK Puduvalli, et al. 2009 Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation Blood 113 3744 3753 19096009 10.1182/blood-2008-09-178707 1:CAS:528:DC%2BD1MXlt1yjsLg%3D
139. PR di Val Cervo P Tucci A Majid, et al. 2009 p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia Blood 113 6498 6499 10.1182/blood-2009-02- 203174 1:CAS:528:DC%2BD1MXnvFGnsb8%3D (author reply 6499-6500)
140. LA Donehower M Harvey BL Slagle, et al. 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 215 221 1552940 10.1038/356215a0 1:CAS:528:DyaK38XitFajsLc%3D
141. EJ Nam H Yoon SW Kim, et al. 2008 MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2690 2695 18451233 10.1158/1078-0432.CCR- 07-1731 1:CAS:528:DC%2BD1cXlsV2qtL8%3D
142. M Bellon Y Lepelletier O Hermine C Nicot 2009 Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia Blood 113 4914 4917 19246560 10.1182/blood-2008-11-189845 1:CAS:528:DC%2BD1MXmslaltr8%3D
143. KH Lee YL Chen SD Yeh, et al. 2009 MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation Oncogene 28 3360 3370 19597470 10.1038/onc.2009.192 1:CAS:528:DC%2BD1MXosFWhsb8%3D
144. M Marabese F Vikhanskaya C Rainelli T Sakai M Broggini 2003 DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1 Nucleic Acids Res 31 6624 6632 14602923 10.1093/nar/gkg869 1:CAS:528:DC%2BD3sXptVCjsbY%3D (Pubitemid 37508769)
145. K Kozaki I Imoto S Mogi K Omura J Inazawa 2008 Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer Cancer Res 68 2094 2105 18381414 10.1158/0008-5472.CAN-07-5194 1:CAS:528:DC%2BD1cXktVyqtbg%3D (Pubitemid 351521781)
146. SD Reddy SB Pakala K Ohshiro SK Rayala R Kumar 2009 MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions Cancer Res 69 5639 5642 19584269 10.1158/0008-5472.CAN-09-0898 1:CAS:528:DC%2BD1MXosV2msrY%3D
147. T Ozaki A Nakagawara 2005 p73, a sophisticated p53 family member in the cancer world Cancer Sci 96 729 737 16271066 10.1111/j.1349-7006.2005.00116.x 1:CAS:528:DC%2BD2MXhtlers7jI (Pubitemid 43019823)
148. L Zhou X Qi JA Potashkin FW Abdul-Karim GI Gorodeski 2008 MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3-untranslated region of the gene that decrease steady-state levels of the transcript J Biol Chem 283 28274 28286 18682393 10.1074/jbc.M802663200 1:CAS:528:DC%2BD1cXht1ans73O
149. YC Lin MW Kuo J Yu, et al. 2008 c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development Mol Biol Evol 25 2189 2198 18667440 10.1093/molbev/msn165 1:CAS:528:DC%2BD1cXht1ektbnO
150. S Tchatchou A Jung K Hemminki, et al. 2009 A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women Carcinogenesis 30 59 64 19028706 10.1093/carcin/bgn253 1:CAS:528:DC%2BD1MXhtVaqu7s%3D
151. X Chen X Guo H Zhang, et al. 2009 Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 1385 1392 19137007 10.1038/onc.2008.474 1:CAS:528:DC%2BD1MXivFCjsLk%3D
152. KR Cordes NT Sheehy MP White, et al. 2009 miR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 705 710 19578358 1:CAS:528:DC%2BD1MXotVClt78%3D
153. Y Akao Y Nakagawa A Iio T Naoe 2009 Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells Leuk Res 33 1530 1538 19464056 10.1016/j.leukres.2009.04.019 1:CAS:528:DC%2BD1MXhtVegs7jM